Drug intelligence / Profile preview

Fluoraphat Pro + VivaSens

Development stage: Unknown
Lead developer: Willmann & Pein
Modality: Small Molecules
Administration: Dental

Overview

Fluoraphat Pro and VivaSens are two distinct in-office dental desensitizing agents used to treat dentine hypersensitivity (DH). Fluoraphat Pro is a desensitizing varnish containing 5% sodium fluoride with melon flavor that seals dentinal tubules effectively. VivaSens is also a commercially available desensitizing agent. Clinical studies have shown that both products are effective in controlling DH, with Fluoraphat Pro demonstrating greater efficiency in relieving dental hypersensitivity compared to VivaSens.

Beyond the preview

Go deeper on Fluoraphat Pro + VivaSens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluoraphat Pro + VivaSens.

Explore the full profile